---
$id: https://graph.org.ai/products/commodity/51342302
$type: Product
source: UNSPSC
code: "51342302"
title: "Buciclovir"
class: "51342300"
classTitle: "Antiviral guanines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Buciclovir

**UNSPSC Code**: 51342302
**Class**: [Antiviral guanines](Antiviral guanines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and antiviral agent with the molecular formula C9H13N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4G4Z4676IS, chemically known as 6h-purin-6-one, 2-amino-9-(3,4-dihydroxybutyl)-1,9-dihydro-, (r)- but generally known as buciclovir, which bears US NIH Compound Identifier 65648. Buciclovir most often comes in base and triphosphate forms. European Medicines Agency schedules Buciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05943MIG. The term BUCICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). BUCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buciclovir under HS 29335995 and SITC 51576. As of Q4 2014, BUCICLOVIR remains the US FDA Preferred Term for this commodity. Buciclovir bears US NLM identifiers UMLS ID C0050178 and NCI Concept Code C73198. SMILES: OC(CCN1C2[NH]C(NC(=O)C2NC1)N)CO.-.

